肝细胞癌
甾醇调节元件结合蛋白
癌症研究
降级(电信)
化学
肝癌
细胞生物学
生物化学
生物
基因
基因表达
电信
计算机科学
作者
Daoyuan Tu,Rui Peng,Shengjie Jin,Bingbing Su,Song-song Fan,Jiahao Zhang,Shunyi Wang,Yang-yang Miao,Guo‐Qing Jiang,Chi Zhang,Jun Cao,Dousheng Bai
标识
DOI:10.1038/s41419-025-07707-9
摘要
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors of the digestive system, and its prevalence is currently increasing. The current study aims to elucidate the mechanism by which membrane-associated RING-CH8 (MARCH8) impedes the progression of HCC. MARCH8 was identified as a distinct prognostic marker for recurrence-free survival (RFS) and overall survival (OS) in patients with HCC. This study shows that MARCH8 hinders lipid deposition by suppressing the expression of key enzymes for the de novo synthesis of fatty acids (FAs) via RNA sequencing, untargeted metabolomics, and a series of in vivo and in vitro experiments. Further experimental validation demonstrated that MARCH8 was a novel E3 ligase of sterol regulatory element binding protein 1 (SREBP1). And, it primarily promoted the degradation of SREBP1, thereby suppressing the expression of key enzymes involved in the de novo synthesis of FAs. In conclusion, this study has identified MARCH8 as a key "switch" that can be targeted to prevent de novo FA synthesis in HCC cells. This finding may have substantial implications for discovering innovative therapeutic strategies for HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI